AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 4c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.81), $0.04 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
• Dell shares surge on record AI server bookings